HIGHLIGHTS
- who: Chiara Cappelletti from the Department of Mechanical, Electronics and Chemical Engineering, Faculty of Technology, and, OsloMetu2014Oslo have published the research work: Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls, in the Journal: (JOURNAL)
- what: Through a proteomic approach the authors aim at identifying dysregulated pathways in activated T cells from MS patients as compared to healthy controls. The authors examined the differences at the proteomic level of C u00ad D4+ T_cells from RRMS patients (n=20) and HCs (n=20). u00adCD4+ T_cells were left unstimulated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.